ConductScience.org, home

Paper39587458

Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis.

Karaca M and 8 others. Med Sci Monit, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis. Papers, record 39587458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39587458

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sarcopenia's Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis.
PubMed
Journal
Med Sci Monit
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.74, provisional
iCite
Revised in PubMed
2024-12-02
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Karaca MMustafa
2Alemdar MSMustafa Serkan
3Deniz Karaca ÖÖzge
4Kılar YYıldız
5Köker GGökhan
6Sözel HHasan
7Yıldız MMustafa
8Özçelik Köker GGülhan
9Arici MÖMustafa Özgürhttps://orcid.org/0000-0001-9821-6368

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SarcopeniaMajor topic
Neoadjuvant TherapyMajor topic
Breast NeoplasmsMajor topic
Humans
Female
Retrospective Studies
Middle Aged
Aged
Adult
Treatment Outcome
Kaplan-Meier Estimate
Psoas Muscles
Chemotherapy, Adjuvant
Neoplasm Staging

Source PubMed

Download CSV of topics

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123908848Lifestyle and sarcopenia-etiology, prevention, and treatment.Rambam Maimonides Med J2012https://conductscience.org/library/papers/23908848PubMed
230139644The impact of preoperative sarcopenia, defined based on psoas muscle area, on long-term outcomes of heart valve surgery.J Thorac Cardiovasc Surg2019https://conductscience.org/library/papers/30139644PubMed
333046106Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018.Health Qual Life Outcomes2020https://conductscience.org/library/papers/33046106PubMed
433294497Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer.Eur J Radiol Open2020https://conductscience.org/library/papers/33294497PubMed
528734552Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review.Clin Nutr2018https://conductscience.org/library/papers/28734552PubMed
624189893Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer.Curr Opin Support Palliat Care2013https://conductscience.org/library/papers/24189893PubMed
714659147A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival.Breast2003https://conductscience.org/library/papers/14659147PubMed
818757321Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer.J Clin Oncol2008https://conductscience.org/library/papers/18757321PubMed
922903527The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer.Oncologist2012https://conductscience.org/library/papers/22903527PubMed
1033557032The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy.Cancers (Basel)2021https://conductscience.org/library/papers/33557032PubMed
1134780924Impact of Sarcopenia on Outcomes of Minimally Invasive Cardiac Surgery.Semin Thorac Cardiovasc Surg2023https://conductscience.org/library/papers/34780924PubMed
1226343952Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes.Semin Cell Dev Biol2016https://conductscience.org/library/papers/26343952PubMed
1319351764Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.Clin Cancer Res2009https://conductscience.org/library/papers/19351764PubMed
1430312372Sarcopenia: revised European consensus on definition and diagnosis.Age Ageing2019https://conductscience.org/library/papers/30312372PubMed
1525925237Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia.J Gastrointest Surg2015https://conductscience.org/library/papers/25925237PubMed
1637354335Hematologic toxicities, sarcopenia, and body composition change in breast cancer patients undergoing neoadjuvant chemotherapy.Support Care Cancer2023https://conductscience.org/library/papers/37354335PubMed
1722144825Cancer cachexia.J Oral Maxillofac Pathol2011https://conductscience.org/library/papers/22144825PubMed
1835933845Rethinking breast cancer follow-up based on individual risk and recurrence management.Cancer Treat Rev2022https://conductscience.org/library/papers/35933845PubMed
1936536266Muscle mass loss in breast cancer patients of reproductive age (≤ 45 years) undergoing neoadjuvant chemotherapy.Radiol Med2023https://conductscience.org/library/papers/36536266PubMed
2027489287Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.Clin Cancer Res2017https://conductscience.org/library/papers/27489287PubMed

See all 36 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42941441Pretreatment Body Composition Parameters and HALP Score in Relation to Pathological Complete Response in HER2-Positive Breast Cancer Receiving Neoadjuvant Systemic Therapy.J Clin Med2026https://conductscience.org/library/papers/42941441PubMed
42779147Predictive Value of CT-Derived Skeletal Muscle Metrics for Pathologic Complete Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.Eur J Breast Health2026https://conductscience.org/library/papers/42779147PubMed
42581091Associations of body composition with neoadjuvant chemotherapy response, toxicity, and prognosis in breast cancer: a scoping review.Cancer Chemother Pharmacol2026https://conductscience.org/library/papers/42581091PubMed
42495721The relationship between sarcopenia and breast cancer: mechanistic pathways and clinical relevance.Front Cell Dev Biol2026https://conductscience.org/library/papers/42495721PubMed
42200373Change in skeletal muscle mass during systemic cancer treatment: a systematic review and meta-analysis.Acta Oncol2026https://conductscience.org/library/papers/42200373PubMed
41010899Low Skeletal Muscle Index as a Predictor of Pathological Complete Response in HER-2 Positive and Triple-Negative Breast Cancer.Medicina (Kaunas)2025https://conductscience.org/library/papers/41010899PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39587458

GET https://conductscience.org/api/papers/v1/39587458/references?page=2